Healthcare -
Biotechnology - NASDAQ - US
$ 5.655
-1.82 %
$ 347 M
Market Cap
-3.18
P/E
GLUE - PRE-TAX INCOME
Pre-tax Income GLUE - Monte Rosa Therapeutics, Inc.
-135 M
LAST VALUE
-35.11%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR